
 |
Welcome to MTS Europe GmbH - welcome to new therapy dimensionsMTS, a subsidiary of Tissue Regeneration Technologies, LLC, United States, is one of the leading companies in development and manufacture of electrohydraulic extracorporeal shockwave therapy systems. Our devices are successfully used in orthopaedics, traumatology, wound management, urology and veterinary medicine worldwide.
Besides development and manufacture, our team significantly engages in clinical research for new medical application areas for electrohydraulic shockwaves. In cooperation with renowned universities and research institutions, MTS and TRT can refer to a large and continuously growing number of scientific studies for various medical indications.
|
|
|
| NEWS + NEWS + NEWS
Prognostic model for the outcome of shockwave therapy for nonunions with orthogold280 etsablished Stojadinovic et al. have established a prognostic naive bayesian model based on 349 nonunion patients. The model predicts 92.1% healing of a tibial shaft nonunion and 97.9% healing of a nonunion of the foot with one single therapy using the orthogold280 when treated between 6 and 11 months after the fracture.
Read more ...
MTS successfully attends Arab Health Exhibition 2011 For the 6th year in row MTS attended Arab Health the most important medical technology exhibition for the MENA region. The enthusiastic feedback from long-time partners in this region as well as from other visitors shows the growing perception of the possibilities of shockwave therapy in the different markets.
Read more ...
MTS high-end lithotriptor receives lithogold380 CE-certification MTS Europe GmbH, Konstanz, Germany, achieves CE-certification of its high-end lithotripter lithogold380. The device approval puts an efficient and tissue-protective therapy for kidney stones within reach of European patients.
Read more ...
|
|
|
|
 |
Meet us at:
Düsseldorf,
16-19 November 2011 MEDICA 2011, Booth 16C41
Kiel, 9-11 June 2011 14th ISMST Congress, Booth 1
Brussels, 26 May 2011 EWMA 2011, Workshop: "Physical treatment modalities", Hall 300
Dubai, 24-27 January 2011 Arab Health 2011, Booth ZD75
Oberwiesenthal, 13-16 January 2011 28th Berlin Arthroscopy Symposium
|